Direkt zum Inhalt
Merck
Alle Fotos(1)

Dokumente

97336

Sigma-Aldrich

D-Sorbit

liquid, tested according to Ph. Eur.

Synonym(e):

Sorbitolum liquidum non cristallisabile, D-Glucitol

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)

About This Item

Empirische Formel (Hill-System):
C6H14O6
CAS-Nummer:
50-70-4
Molekulargewicht:
182.17
Beilstein:
1721899
EG-Nummer:
200-061-5
MDL-Nummer:
MFCD00004708
UNSPSC-Code:
12352201
PubChem Substanz-ID:
329770356
NACRES:
NA.21

Agentur

USP/NF
tested according to Ph. Eur.

Qualitätsniveau

100

Dampfdichte

<1 (vs air)

Dampfdruck

<0.1 mmHg ( 25 °C)

Assay

72-92%

Form

liquid

Verunreinigungen

28-32% water

Farbe

white

Nützlicher pH-Bereich

5.0-7 (25 °C, 182 g/L)

mp (Schmelzpunkt)

98-100 °C (lit.)

Löslichkeit

water: soluble 182 g/L at 20 °C (68 °F)

SMILES String

OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)CO

InChI

1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2/t3-,4+,5-,6-/m1/s1

InChIKey

FBPFZTCFMRRESA-JGWLITMVSA-N

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Verwandte Kategorien

Sonstige Hinweise

To gain a comprehensive understanding of our extensive range of Sugar alcohols for your research, we encourage you to visit our Carbohydrates Category page.

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 1

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable

Persönliche Schutzausrüstung

Eyeshields, Gloves, type N95 (US)

Choose from one of the most recent versions:

Analysenzertifikate (COA)

Lot/Batch Number
BCCM1306
BCCL7069
BCCL3093
BCCK9604
BCCK1576

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Kunden haben sich ebenfalls angesehen

Slide 1 of 6

1 of 6

Sorbit European Pharmacopoeia (EP) Reference Standard

S1000000

Sorbit

Sorbit United States Pharmacopeia (USP) Reference Standard

USP

1617000

Sorbit

Parteck&#174; SI 400 LEX (Sorbit) EMPROVE&#174; EXPERT, Ph. Eur., BP, NF, JP

SAFC

1.11597

Parteck® SI 400 LEX (Sorbit)

D-Sorbit &#8805;98% (GC), for molecular biology

Sigma-Aldrich

S6021

D-Sorbit

Parteck&#174; SI 400 (Sorbit) EMPROVE&#174; ESSENTIAL, Ph. Eur., BP, NF, FCC, E 420, JSFA

SAFC

1.03140

Parteck® SI 400 (Sorbit)

Sorbit Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1006

Sorbit

Reddy Ranjith K Sama et al.
Journal of cellular physiology, 228(11), 2222-2231 (2013-04-30)
FUsed in Sarcoma/Translocated in LipoSarcoma (FUS/TLS or FUS) has been linked to several biological processes involving DNA and RNA processing, and has been associated with multiple diseases, including myxoid liposarcoma and amyotrophic lateral sclerosis (ALS). ALS-associated mutations cause FUS to
G Molino et al.
The Journal of laboratory and clinical medicine, 131(5), 393-405 (1998-05-30)
D-Sorbitol (SOR) is safe, is easy to measure, and has an exceptionally high extraction ratio in the normal liver of 0.93+/-0.05 (mean+/-SD). Together with the general interest in hepatic hemodynamics, these facts motivated us to review the usefulness of this
Shahram Attarian et al.
Orphanet journal of rare diseases, 9, 199-199 (2014-12-19)
Charcot-Marie-Tooth type 1A disease (CMT1A) is a rare orphan inherited neuropathy caused by an autosomal dominant duplication of a gene encoding for the structural myelin protein PMP22, which induces abnormal Schwann cell differentiation and dysmyelination, eventually leading to axonal suffering
Arlene E Dent et al.
PloS one, 3(10), e3557-e3557 (2008-10-30)
Antibodies that impair Plasmodium falciparum merozoite invasion and intraerythrocytic development are one of several mechanisms that mediate naturally acquired immunity to malaria. Attempts to correlate anti-malaria antibodies with risk of infection and morbidity have yielded inconsistent results. Growth inhibition assays
J M van Griensven et al.
Clinical pharmacology and therapeutics, 58(6), 631-640 (1995-12-01)
To examine the effect of diabetes mellitus on the pharmacokinetics of tolrestat and to investigate its effect on red blood cell sorbitol levels according to a new pharmacodynamic model for this class of drugs. Single and multiple doses of tolrestat
Alle zugehörigen Dokumente anzeigen

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.